Evidence map›Paper›PMID 26183782›Full record

ArticleThe Journal of biological chemistry2015

Apoptotic cells activate AMP-activated protein kinase (AMPK) and inhibit epithelial cell growth without change in intracellular energy stores.

Vimal A Patel, Donald Massenburg, Snezana Vujicic, Lanfei Feng, Meiyi Tang, Natalia Litbarg, Angelika Antoni, Joyce Rauch, Wilfred Lieberthal, Jerrold S Levine

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Adenosinergic signaling as a target for natural killer cell immunotherapy.Journal of molecular medicine (Berlin, Germany) · 2018
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Vimal A PatelFrom the Section of Nephrology, Departments of Medicine and the Section of Nephrology, Department of Medicine, Jesse Brown Veterans Affairs Hospital, Chicago, Illinois 60612.
Donald MassenburgFrom the Section of Nephrology, Departments of Medicine and the Section of Nephrology, Department of Medicine, Jesse Brown Veterans Affairs Hospital, Chicago, Illinois 60612.
Snezana VujicicFrom the Section of Nephrology, Departments of Medicine and the Section of Nephrology, Department of Medicine, Jesse Brown Veterans Affairs Hospital, Chicago, Illinois 60612.
Lanfei FengFrom the Section of Nephrology, Departments of Medicine and the Section of Nephrology, Department of Medicine, Jesse Brown Veterans Affairs Hospital, Chicago, Illinois 60612.
Meiyi Tangthe Section of Nephrology, Department of Medicine, Stony Brook University Medical Center, Stony Brook, New York 11794, the Northport Veterans Affairs Hospital, Northport, New York 11768.
Natalia LitbargFrom the Section of Nephrology, Departments of Medicine and the Section of Nephrology, Department of Medicine, Jesse Brown Veterans Affairs Hospital, Chicago, Illinois 60612.
Angelika Antonithe Department of Biology, Kutztown University of Pennsylvania, Kutztown, Pennsylvania 19530, and.
Joyce Rauchthe Division of Rheumatology, Department of Medicine, Research Institute of the McGill University Health Centre, Montreal, Quebec H4A 3J1, Canada.
Wilfred Lieberthalthe Section of Nephrology, Department of Medicine, Stony Brook University Medical Center, Stony Brook, New York 11794, the Northport Veterans Affairs Hospital, Northport, New York 11768.
Jerrold S LevineFrom the Section of Nephrology, Departments of Medicine and the Section of Nephrology, Department of Medicine, Jesse Brown Veterans Affairs Hospital, Chicago, Illinois 60612, Microbiology and Immunology, University of Illinois, Chicago, Illinois 60612, jslevine@uic.edu.
University of Illinois Chicago · USJesse Brown VA Medical Center · USKutztown University · USMcGill University Health Centre · CANorthport VA Medical Center · USStony Brook University Hospital · US

Funding

Acquisition of a Triple Quadrupole Mass SpectrometerS10RR024516 · NCRR · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI LI, ZHONG · 2009 to 2009
$469k
Canadian Institutes of Health Research MOP-67101Canadian Institutes of Health Research MOP-97916NCRR NIH HHS S10 RR024516NCRR NIH HHS S10RR024516
6 · The paper itself

Abstract

Apoptosis plays an indispensable role in the maintenance and development of tissues. We have shown that receptor-mediated recognition of apoptotic target cells by viable kidney proximal tubular epithelial cells (PTECs) inhibits the proliferation and survival of PTECs. Here, we examined the effect of apoptotic targets on PTEC cell growth (cell size during G1 phase of the cell cycle). Using a cell culture model, we show that apoptotic cells potently activate AMP-activated protein kinase (AMPK), a highly sensitive sensor of intracellular energy stores. AMPK activation leads to decreased activity of its downstream target, ribosomal protein p70 S6 kinase (p70S6K), and concomitant inhibition of cell growth. Importantly, these events occur without detectable change in intracellular levels of AMP, ADP, or ATP. Inhibition of AMPK, either pharmacologically by compound C or molecularly by shRNA, diminishes the effects of apoptotic targets and largely restores p70S6K activity and cell size to normal levels. Apoptotic targets also inhibit Akt, a second signaling pathway regulating cell growth. Expression of a constitutively active Akt construct partially relieved cell growth inhibition but was less effective than inhibition of AMPK. Inhibition of cell growth by apoptotic targets is dependent on physical interaction between apoptotic targets and PTECs but independent of phagocytosis. We conclude that receptor-mediated recognition of apoptotic targets mimics the effects of intracellular energy depletion, activating AMPK and inhibiting cell growth. By acting as sentinels of environmental change, apoptotic death may enable nearby viable cells, especially nonmigratory epithelial cells, to monitor and adapt to local stresses.

Indexed as

Adenine NucleotidesAMP-Activated Protein KinasesAnimalsApoptosisCell ProliferationEnergy MetabolismEpithelial CellsKidney Tubules, ProximalMiceMice, TransgenicProto-Oncogene Proteins c-aktRibosomal Protein S6 Kinases, 70-kDaSignal TransductionAdenine NucleotidesAMP-Activated Protein KinasesProto-Oncogene Proteins c-aktRibosomal Protein S6 Kinases, 70-kDaADPAkt PKBAMPAMP-activated kinase (AMPK)apoptosisATPcell growthepithelial cellinnate immunitykidney

Identifiers

PMID26183782
PMCPMC4566212
OpenAlexW2396197369

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.